You are viewing the site in preview mode

Skip to main content

Advertisement

Table 1 Direct and indirect costs avoided by the MRSA screening and isolation program

From: Review of a two-year methicillin-resistant Staphylococcus aureus screening program and cost-effectiveness analysis in Singapore

Parameter Number of colonized patients Number of Infected patients Cost per day ($US) Total cost ($US)
Direct cost
 Hospital bill per day for infectious disease patient 14 5a 228 4469b
 Hospital bill per day for dermatological patient 162 57a 372 63,277c
 Hospital bill per day stay for HIV patient 97 34a 226 36,123d
 Total direct cost     103,869
Indirect cost
 Productivity loss of infectious disease patient 14 5a 155e 2803
 Productivity loss of dermatological patient 162 57a 155e 24,324
 Productivity loss of HIV patient 97 34a 155e 19,419
 Total indirect cost     50,453
  1. aThirty-five percent of the colonized patients are assumed to progress to infection
  2. bBased on four additional hospitalization days and five Infectious disease patients estimated to be progressed to infection
  3. cBased on three additional hospitalization days and 57Dermatological patients estimated to be progressed to infection
  4. dBased on four additional hospitalization days and 34HIV patients estimated to be progressed to infection
  5. eEstimated based on GDP per capita of $US 55,183 [36]